Enanta Pharmaceuticals, Inc.

ENTA

$14.02

-0.50%

N/A-$0.07

Healthcare

Biotechnology

NASDAQ

Active Trading

Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral ...

Historical Employee Count of ENTA

Current

120

Change

-8.40%

Minimum

120

Maximum

160

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Sep 30, 2025	120	10-K	Nov 19, 2025	View
Sep 30, 2024	131	10-K	Nov 27, 2024	View
Sep 30, 2023	145	10-K	Nov 22, 2023	View
Sep 30, 2022	160	10-K	Nov 23, 2022	View
Sep 30, 2021	155	10-K	Nov 24, 2021	View

Supply Chain of ENTA

Upstream / Downstream / Proxies

Upstream

AbbVie Inc.NYSE:ABBV Thermo Fisher Scientific Inc. (Patheon CDMO)NYSE:TMOUnnamed CDMOs (Clinical-Stage Drug Substance & Drug Product Manufacturers)Unnamed CROs (Clinical Research Organizations)Laboratory Reagent & Equipment Suppliers (Thermo Fisher, MilliporeSigma, Agilent, etc.)Unnamed APCIs / Fine Chemical SuppliersUnnamed Excipient & Packaging Suppliers

Downstream

AbbVie Inc.NYSE:ABBVOMERS Life Sciences (OMERS Capital Partners)National Institute of Allergy and Infectious Diseases (NIAID)Shionogi & Co., Ltd.TSE:4507Novartis AGNYSE:NVS

Proxies

Royalty Pharma plcNASDAQ:RPRX Atea Pharmaceuticals, Inc.NASDAQ:AVIR BioCryst Pharmaceuticals, Inc.NASDAQ:BCRX Arvinas, Inc.NASDAQ:ARVN

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer